BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26045861)

  • 1. A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis.
    Ding J; Jiang L; Gan Y; Wu W
    Int J Clin Exp Pathol; 2015; 8(3):3322-7. PubMed ID: 26045861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer. Its relation with molecular subtypes].
    Ruano R; Ramos M; García-Talavera JR; Ramos T; Rosero AS; González-Orus JM; Sancho M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):340-5. PubMed ID: 24856234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature.
    Li D; Xiao X; Yang W; Shui R; Tu X; Lu H; Shi D
    Mod Pathol; 2012 Apr; 25(4):567-75. PubMed ID: 22157932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
    Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
    Lian J; Wang LX; Guo JH; Bu P; Xi YF; Yun KM
    Diagn Pathol; 2021 Oct; 16(1):89. PubMed ID: 34629079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer.
    Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN
    Tumori; 2014; 100(1):80-6. PubMed ID: 24675496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory breast carcinoma in a boy.
    Yildirim E; Turhan N; Pak I; Berberoğlu U
    Eur J Surg Oncol; 1999 Feb; 25(1):98-9. PubMed ID: 10188866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secretory breast carcinoma in a man. A case report with rapid evolution unfavorable].
    Woto-Gaye G; Kasse AA; Dieye Y; Toure P; Demba Ndiaye P
    Ann Pathol; 2004 Oct; 24(5):432-5; quiz 393. PubMed ID: 15738869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma.
    Chu Z; Lin H; Liang X; Huang R; Tang J; Bao Y; Jiang J; Zhan Q; Zhou X
    Jpn J Clin Oncol; 2015 Jul; 45(7):637-41. PubMed ID: 25862826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases.
    Lee SM; Kang EJ; Kim JH; Yun JM; Sun DS; Ko YH; Won HS
    Korean J Intern Med; 2015 May; 30(3):411-4. PubMed ID: 25995674
    [No Abstract]   [Full Text] [Related]  

  • 11. Pure mucinous carcinoma with axillary lymph node metastasis in a male breast.
    Dragoumis DM; Assimaki AS; Tsiftsoglou AP
    Breast Cancer; 2012 Oct; 19(4):365-8. PubMed ID: 19756925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast carcinoma in a 7-years- old girl.
    Tadesse A; Tesfaye W; Hailemariam B
    Ethiop Med J; 2012 Jan; 50(1):89-94. PubMed ID: 22519165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tumor budding count is associated with adverse clinicopathologic features and poor prognosis in breast carcinoma.
    Li X; Wei B; Sonmez C; Li Z; Peng L
    Hum Pathol; 2017 Aug; 66():222-229. PubMed ID: 28655638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.
    Vasudev P; Onuma K
    Arch Pathol Lab Med; 2011 Dec; 135(12):1606-10. PubMed ID: 22129193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up.
    Wynveen CA; Nehhozina T; Akram M; Hassan M; Norton L; Van Zee KJ; Brogi E
    Am J Surg Pathol; 2011 Jan; 35(1):1-14. PubMed ID: 21084964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male breast cancer: A 10 year retrospective case series in a tertiary care hospital.
    Yetkin G; Celayir MF; Tanik C; Citgez B; Uludag M; Mihmanli M
    J Pak Med Assoc; 2019 Aug; 69(8):1209-1212. PubMed ID: 31431782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adenoid cystic carcinoma of the breast:report of 25 cases].
    Wei L; Liang X; Li S; Liu J
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):147-50. PubMed ID: 24796466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
    Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
    Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-evaluating the role of sentinel lymph node biopsy in microinvasive breast carcinoma.
    Hanna MG; Jaffer S; Bleiweiss IJ; Nayak A
    Mod Pathol; 2014 Nov; 27(11):1489-98. PubMed ID: 24743214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.